MINNEAPOLIS, Oct. 27, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the company is scheduled to present at the Stifel 2016 Healthcare Conference in New York City on Wednesday, November 16th at 11:00am (EST). The company will also present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York City on Thursday, November 17th at 11:00am (EST).
Howard Root, Chief Executive Officer of Vascular Solutions, will deliver the company’s presentations. To hear the live audio webcast of the Vascular Solutions’ presentation, go to the investor relations page of the company’s web site www.vasc.com and click on the “Investor Conferences” icon a few minutes prior to start time to download any necessary software.
About Stifel, Nicolaus & Company
Stifel Financial Corp. (NYSE:SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated; Keefe Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Century Securities Associates, Inc., and in the United Kingdom and Europe through Stifel Nicolaus Europe Limited. More information is available at www.stifel.com.
About Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Genuity Group Inc. offering institutional and corporate clients idea-driven investment banking, merger and acquisition, research, sales and trading services from offices in 10 countries worldwide. More information is available at www.canaccordgenuity.com.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company has launched more than 100 products that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists through its direct U.S. sales force and international independent distributor network.
Contact: Phil Nalbone, VP Vascular Solutions, Inc. (763) 656-4300


Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 



